Tag: Nasdaq
-
Chip Designer Arm IPOs 10% over its debut price but questions arise on valuation
Chip designer Arm (ARM:Nasdaq) launched its initial public offering today (September 14th 2023). The ARM IPO priced 95.5 million shares at $51 per share at a valuation of $54.5 billion on a fully diluted basis. This $51 was the high end of the expected range of $47-$51. Arm came out swinging. The open price was…
-
Jerome Powell signals higher rates may be needed
When Nvidia blew out earnings, many saw it as a catalyst to see stock markets break out higher. However, certain technical patterns and levels I have been highlighting in my Market Moment articles told my readers and I that the downtrend was not over. This, I believe, is the power of technical analysis. But fundamental…
-
World stock markets tumble as bond yields rise
Global equity markets are selling off hard this morning as the probability of more rate hikes increase. The real action is in the bond markets as yields are rising. The US 2 year yield actually broke out into new recent highs taking out the March 2023 peak. The 10 year yield is also breaking out…
-
Stock markets approach key resistance. Is a new downtrend about to begin?
What a month it has been for US stock markets. US markets have been in hard rally mode since June 1st 2023, with the Nasdaq seeing its rally begin on May 24th 2023. A few other markets in the world are joining in on the party. Japan’s Nikkei continues to break decades long records largely…
-
Does this weeks earnings point to a recession?
The US stock markets continue their chop fest and range as the rally to start 2023 is set to be tested by first quarter earnings. Investors have been expecting earnings to be somewhat mixed or tepid as higher interest rates begin showing their impact on the real economy and resulting in an economic slowdown or…
-
Have US stock markets established their bear market lows?
Have US stock markets bottomed? From a technical analysis perspective: yes, there is a very good chance they have. From a fundamental perspective: it gets complicated. If we consider fundamentals, there is a lot which can weigh in on markets. Some things to consider are: Earnings, China, Russia, Inflation, Interest Rates, Supply Chain Issues, European…
-
Medexus Pharmaceuticals (MDP.V), poised for flight on the Nasdaq (coming soon)
If you are like me and health sciences is your sector of choice when it comes to investing in the markets, you’d better be very patient, love doing research – and a willingness to see it through!!! A sector famous for its high-risk-high-reward characteristics is definitely not recommended for the faint of heart. Lucky for…
-
Immunoprecise Antibodies (IPA.V), or should I say (NASDAQ: IPA)
Before we start, let’s give a big round of applause to Immunoprecise Antibodies Ltd and all its staff and its management. They are headed to the big leagues, ladies and gentlemen – a straight path towards listing on the Nasdaq (begin trading on Nasdaq on December 30th, 2020). I’m not a parent myself (unless you…